Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
You can save money and still enjoy life. Discover creative ways to balance your lifestyle with your financial goals.
27,563 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Gabelli’s team signals a long-running capex wave in defense, benefiting both the big primes and smaller suppliers. Al...
Ethereum activity on Binance surged to a six-month peak as volatility returns. Analysts note heavy turnover and fast-...
A draft U.S. framework for AI chip exports proposes tiered licensing, potentially slowing big orders and shifting mar...
As 2026 budget cycles unfold, investors are rethinking how the weapons that built army legacy translate into today’s ...
A hypothetical move where Paramount aligns with Warner Bros. Discovery would ripple through streaming, financing, and...
Oil prices surged to multi-week highs, sending Apple, Tesla, and Alphabet down in after-hours trading while Nasdaq fu...
Berkshire Hathaway disclosed a surprise move this quarter: net selling of big positions and a cash hoard that swelled...
Mega-cap tech names are offering ballast as markets wobble, but the rally is fragile and depends on earnings momentum...
Oil futures fell about 8% as energy ministers prepared to discuss emergency reserve releases. The move comes amid ong...
Three utility ETFs are posting eye-catching gains as data-center demand grows, underscoring a new growth era for the ...
Investors are parsing sector headlines as analysts cut targets for airlines and other cyclical stocks. This guide bre...